Results
|
|
141.
|
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours. [electronic resource] by
- Boss, D S
- Schwartz, G K
- Middleton, M R
- Amakye, D D
- Swaisland, H
- Midgley, R S
- Ranson, M
- Danson, S
- Calvert, H
- Plummer, R
- Morris, C
- Carvajal, R D
- Chirieac, L R
- Schellens, J H M
- Shapiro, G I
Producer: 20100622
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
|
142.
|
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors. [electronic resource] by
- Milojkovic Kerklaan, B
- Slater, S
- Flynn, M
- Greystoke, A
- Witteveen, P O
- Megui-Roelvink, M
- de Vos, F
- Dean, E
- Reyderman, L
- Ottesen, L
- Ranson, M
- Lolkema, M P J
- Plummer, R
- Kristeleit, R
- Evans, T R J
- Schellens, J H M
Producer: 20171219
In:
Investigational new drugs vol. 34
Availability: No items available.
|
|
|
143.
|
SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. [electronic resource] by
- Harris, N L E
- Vennin, C
- Conway, J R W
- Vine, K L
- Pinese, M
- Cowley, M J
- Shearer, R F
- Lucas, M C
- Herrmann, D
- Allam, A H
- Pajic, M
- Morton, J P
- Biankin, A V
- Ranson, M
- Timpson, P
- Saunders, D N
Producer: 20170925
In:
Oncogene vol. 36
Availability: No items available.
|
|
|
144.
|
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors. [electronic resource] by
- Soria, J C
- Gan, H K
- Blagden, S P
- Plummer, R
- Arkenau, H T
- Ranson, M
- Evans, T R J
- Zalcman, G
- Bahleda, R
- Hollebecque, A
- Lemech, C
- Dean, E
- Brown, J
- Gibson, D
- Peddareddigari, V
- Murray, S
- Nebot, N
- Mazumdar, J
- Swartz, L
- Auger, K R
- Fleming, R A
- Singh, R
- Millward, M
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
145.
|
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. [electronic resource] by
- Omlin, A
- Jones, R J
- van der Noll, R
- Satoh, T
- Niwakawa, M
- Smith, S A
- Graham, J
- Ong, M
- Finkelman, R D
- Schellens, J H M
- Zivi, A
- Crespo, M
- Riisnaes, R
- Nava-Rodrigues, D
- Malone, M D
- Dive, C
- Sloane, R
- Moore, D
- Alumkal, J J
- Dymond, A
- Dickinson, P A
- Ranson, M
- Clack, G
- de Bono, J
- Elliott, T
Producer: 20160216
In:
Investigational new drugs vol. 33
Availability: No items available.
|